CNJ-016 (Vaccinia Immune Globulin (Human))
VIGIV (vaccinia immune globulin intravenous, human) is indicated for the treatment and/or modification of the following conditions: Eczema vaccinatum. Progressive vaccinia. …
As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.